Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
Completed · Phase 2 · Has a placebo group
Conditions studied: Dry Eye Syndrome
In brief
The objective of the Phase 2 study is to compare the safety and efficacy of cis-UCA Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.
Key facts
- Study ID
- NCT02326090
- Run by
- Herantis Pharma Plc.
- People needed
- 161
- Starts
- 2014-12-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2015-09-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.